Molecular hydrogen therapies and the benefits for menopausal and perimenopausal women: An aphoristic review
1 Department of Applied Sciences, University of the West of England, Bristol BS16 1QY, UK.
2 Water Fuel Engineering, Church Street, Wakefield WF1 5QY, UK.
Review Article
GSC Biological and Pharmaceutical Sciences, 2022, 21(02), 112–115.
Article DOI: 10.30574/gscbps.2022.21.2.0427
Publication history:
Received on 01 October 2022; revised on 06 November 2022; accepted on 09 November 2022
Abstract:
Women account for half of the global population, yet, when applying of the principles of legislation to women's health and gender-based research there is a void pertaining to women-specific healthcare as they age. Hydrogen therapies such as oxy-hydrogen (HHO, H2/O2) inhalation act as a novel, non-toxic, antioxidant and anti-inflammatory compounds, with clinical and empirical research confidently suggesting such therapies may be beneficial to human reproductive health. This aphoristic review highlights the need for medical evidence-based research into female-focused age conditioning and offers an explanation as to why HHO therapies may be effective in combatting menopausal and perimenopausal symptoms.
Keywords:
Molecular Hydrogen; Menopause; Oxy-hydrogen; Perimenopause
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
